Literature DB >> 20023048

Caveat medicus! Pulmonary hypertension in the elderly: a word of caution.

Barry A Boilson1, John A Schirger, Barry A Borlaug.   

Abstract

Heart failure with preserved ejection fraction (HFpEF) is a common but under-recognized cause of pulmonary hypertension (PH), particularly among the elderly. While elevated pulmonary artery pressures are clearly associated with increased mortality in HFpEF, it remains unknown whether or how pulmonary vascular disease in HFpEF should be treated. This case emphasizes the importance of maintaining a high index of suspicion for HFpEF in elderly patients presenting with PH and illustrates potential hazards associated with selective pulmonary vasodilation in this growing population.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20023048     DOI: 10.1093/eurjhf/hfp171

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  10 in total

1.  Effects of sildenafil on ventricular and vascular function in heart failure with preserved ejection fraction.

Authors:  Barry A Borlaug; Gregory D Lewis; Steven E McNulty; Marc J Semigran; Martin LeWinter; Horng Chen; Grace Lin; Anita Deswal; Kenneth B Margulies; Margaret M Redfield
Journal:  Circ Heart Fail       Date:  2015-03-17       Impact factor: 8.790

2.  The β-Adrenergic Agonist Albuterol Improves Pulmonary Vascular Reserve in Heart Failure With Preserved Ejection Fraction.

Authors:  Yogesh N V Reddy; Masaru Obokata; Katlyn E Koepp; Alexander C Egbe; Brandon Wiley; Barry A Borlaug
Journal:  Circ Res       Date:  2019-01-18       Impact factor: 17.367

Review 3.  Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment.

Authors:  Barry A Borlaug; Walter J Paulus
Journal:  Eur Heart J       Date:  2010-12-07       Impact factor: 29.983

Review 4.  Left ventricular dysfunction with pulmonary hypertension: part 2: prognosis, noninvasive evaluation, treatment, and future research.

Authors:  Andreas P Kalogeropoulos; Vasiliki V Georgiopoulou; Barry A Borlaug; Mihai Gheorghiade; Javed Butler
Journal:  Circ Heart Fail       Date:  2013-05       Impact factor: 8.790

Review 5.  Heart failure with preserved ejection fraction.

Authors:  James D Gladden; Wolfgang A Linke; Margaret M Redfield
Journal:  Pflugers Arch       Date:  2014-03-25       Impact factor: 3.657

6.  Impaired Right Ventricular-Pulmonary Arterial Coupling and Effect of Sildenafil in Heart Failure With Preserved Ejection Fraction: An Ancillary Analysis From the Phosphodiesterase-5 Inhibition to Improve Clinical Status And Exercise Capacity in Diastolic Heart Failure (RELAX) Trial.

Authors:  Imad Hussain; Selma F Mohammed; Paul R Forfia; Gregory D Lewis; Barry A Borlaug; Dianne S Gallup; Margaret M Redfield
Journal:  Circ Heart Fail       Date:  2016-04       Impact factor: 8.790

7.  Acute hemodynamic effects of riociguat in patients with pulmonary hypertension associated with diastolic heart failure (DILATE-1): a randomized, double-blind, placebo-controlled, single-dose study.

Authors:  Diana Bonderman; Ingrid Pretsch; Regina Steringer-Mascherbauer; Pavel Jansa; Stephan Rosenkranz; Caroline Tufaro; Andja Bojic; Carolyn S P Lam; Reiner Frey; Michael Ochan Kilama; Sigrun Unger; Lothar Roessig; Irene M Lang
Journal:  Chest       Date:  2014-11       Impact factor: 9.410

8.  Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: a multicenter, double-blind, randomized clinical trial.

Authors:  Javier Bermejo; Raquel Yotti; Rocío García-Orta; Pedro L Sánchez-Fernández; Mario Castaño; Javier Segovia-Cubero; Pilar Escribano-Subías; José Alberto San Román; Xavier Borrás; Angel Alonso-Gómez; Javier Botas; María G Crespo-Leiro; Sonia Velasco; Antoni Bayés-Genís; Amador López; Roberto Muñoz-Aguilera; Eduardo de Teresa; José R González-Juanatey; Arturo Evangelista; Teresa Mombiela; Ana González-Mansilla; Jaime Elízaga; Javier Martín-Moreiras; José M González-Santos; Eduardo Moreno-Escobar; Francisco Fernández-Avilés
Journal:  Eur Heart J       Date:  2018-04-14       Impact factor: 29.983

9.  Beraprost Sodium for Pulmonary Hypertension in Dogs: Effect on Hemodynamics and Cardiac Function.

Authors:  Ryohei Suzuki; Yunosuke Yuchi; Takahiro Saito; Yuyo Yasumura; Takahiro Teshima; Hirotaka Matsumoto; Hidekazu Koyama
Journal:  Animals (Basel)       Date:  2022-08-15       Impact factor: 3.231

10.  Impact of a volume challenge on haemodynamics and prognosis in patients with severe aortic stenosis.

Authors:  Micha T Maeder; Lukas Weber; Daniel Weilenmann; Philipp K Haager; Lucas Joerg; Franziska Rohner; Peter Ammann; Joannis Chronis; Johannes Rigger; Hans Rickli
Journal:  ESC Heart Fail       Date:  2020-11-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.